CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)
作者： Jankowski Vera , Jankowski Joachim , Liehn Elisa-Anamaria
DOI:
关键词:
摘要: The invention relates to a vasoconstriction-inhibiting factor (VIF) or nuclei acid encoding same, for the prophylaxis and/or treatment of effects heart disease. further pharmaceutical compositions that contain VIF and viable (combination) therapies, in particular using according invention. also kit non-therapeutic in-vitro use, containing nucleic same.
lens.org 参考文章(9)
Adelina Curaj, Sakine Simsekyilmaz, Mareike Staudt, Elisa Liehn, Minimal invasive surgical procedure of inducing myocardial infarction in mice. Journal of Visualized Experiments. ,(2015) , 10.3791/52197
Silvia Salem, Vera Jankowski, Yaw Asare, Elisa Liehn, Pia Welker, Ana Raya-Bermudez, Carmen Pineda-Martos, Mariano Rodriguez, Juan Rafael Muñoz-Castañeda, Heike Bruck, Nikolaus Marx, Fernanda B. Machado, Mareike Staudt, Georg Heinze, Walter Zidek, Joachim Jankowski, Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor Circulation. ,vol. 131, pp. 1426- 1434 ,(2015) , 10.1161/CIRCULATIONAHA.114.013168
T.F. Smith, M.S. Waterman, Identification of common molecular subsequences. Journal of Molecular Biology. ,vol. 147, pp. 195- 197 ,(1981) , 10.1016/0022-2836(81)90087-5
Tam Minh Tran, Nhat Minh Giang, Changes in blood pressure classification, blood pressure goals and pharmacological treatment of essential hypertension in medical guidelines from 2003 to 2013 IJC Metabolic & Endocrine. ,vol. 2, pp. 1- 10 ,(2014) , 10.1016/J.IJCME.2014.01.001
Hartmut Selle, Gabriele Heine, Jens Lamerz, Thomas Moehring, Ruediger Hess, Michael Juergens, Markus Kellmann, Norbert Lamping, Hans-Dieter Zucht, Method for detecting alzheimer’s disease and corresponding peptides and detection reagents ,(2004)
Das Arterielle System Steinkopff. ,(1974) , 10.1007/978-3-642-85290-9
Karen B. Helle, Marie-Helene Metz-Boutigue, Maria Carmela Cerra, Tommaso Angelone, Chromogranins: from discovery to current times Pflügers Archiv: European Journal of Physiology. ,vol. 470, pp. 143- 154 ,(2018) , 10.1007/S00424-017-2027-6
Anett H. Ottesen, Geir Christensen, Torbjørn Omland, Helge Røsjø, Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure. Current Heart Failure Reports. ,vol. 14, pp. 478- 488 ,(2017) , 10.1007/S11897-017-0360-X
Delong Thomas, Haskins Kathryn, COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AUTOIMMUNE DISEASES ,(2018)